冠状动脉微血管功能障碍中的心肌细胞生物标志物:对Ranolazine的反应
Katherine E Hampilos1, Anum Asif2, Puja K Mehta3
1Barbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA.
概括
在冠状动脉微血管功能障碍 (CMD) 患者中,超高灵敏度心脏托罗素I (u-hs-TnI) 水平较高与在用罗纳治疗时心肌缺血的改善相关,这表明它是预防心力衰竭的潜在治疗标.
科学领域:
- 心脏病学 心脏病学
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 是心力衰竭的重要危险因素,其中包括心力衰竭的保存喷射分数 (HFpEF).
- 心肌生物标志物和心室功能障碍评估对于评估CMD严重程度和预后至关重要.
- 作为一种晚期的通道抑制剂的兰诺,目前正在研究其在CMD中的潜在治疗作用.
研究的目的:
- 为了研究基线心肌生物标志物 (u-hs-TnI和NT-proBNP) 与用ranolazine治疗的CMD患者的缺血改善之间的关系.
- 为了确定 u-hs-TnI 或 NT-proBNP 的较高水平是否预测在心肌 perfusion 和胸痛症状方面,对 ranolazine 治疗的反应更大.
主要方法:
- 来自RWISE试验 (NCT01342029) 的数据分析,涉及随机分配给罗纳或安慰剂的CMD参与者.
- 使用全球心肌输液储备指数 (∆MPRI) 和西雅图心痛问卷 (∆SAQ) 的变化评估缺血反应.
- 基线u-hs-TnI和NT-proBNP水平与测量的缺血反应参数之间的相关性分析.
主要成果:
- 在接受罗纳拉治疗的患者中,在较高的基线u-hs-TnI水平和改善的∆MPRI之间观察到具有统计学意义的正相关性 (r=0.26,p=0.04).
- 在u-hs-TnI水平和∆SAQ之间没有发现显著的相关性,在NT-proBNP水平和∆MPRI或∆SAQ之间也没有发现显著的相关性.
- 这些发现是基于对64名u-hs-TnI和40名NT-proBNP参与者的分析.
结论:
- 在CMD患者中,升高的u-hs-TnI水平可能表明,随着ranolazine治疗,缺血症改善的可能性更大.
- 兰诺在改善心肌缺血症中表现有前途,特别是在患有较高u-hs-TnI的患者中.
- 需要进一步的研究,以探索 ranolazine 和其他针对缺血的疗法,以预防 CMD 患者的 HFpEF.
相关概念视频
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
432
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
432
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
76
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
76
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
40
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40